𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relevance of tumor necrosis factor to graft-versus-host disease after small bowel transplantation

✍ Scribed by J. Pirenne; M. D'Silva; G. Degiovanni; N. Jacquet; D. L. Dunn

Publisher
Springer
Year
1993
Tongue
English
Weight
563 KB
Volume
6
Category
Article
ISSN
0934-0874

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Acute graft-versus-host disease after li
Acute graft-versus-host disease after liver transplant: Novel use of etanercept and the role of tumor necrosis factor Ξ± inhibitors
✍ Lena Thin; Gerry MacQuillan; Leon Adams; George Garas; Cynthia Seow; Paul Cannel πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 160 KB πŸ‘ 1 views

Acute graft-versus-host disease following orthotopic liver transplantation is a rare but feared complication arising in 1% to 2% of cases with a dismal prognosis. It most often presents as fever, rash, and diarrhea with or without pancytopenia. Patients die from complications of marrow failure such

Recombinant human soluble tumor necrosis
Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
✍ Alessandro Busca; Franco Locatelli; Filippo Marmont; Cristina Ceretto; Michele F πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 2 views

## Abstract Etanercept is a recombinant human soluble tumor necrosis factor (TNF‐α) receptor fusion protein that inhibits TNF‐α, a major mediator in the pathogenesis of graft‐versus‐host disease (GVHD). The purpose of our study was to evaluate the safety and efficacy of etanercept therapy in 21 pat